Citation Impact
Citing Papers
Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan
2003 StandoutScience
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA
2004 StandoutScience
Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility
2003 StandoutNobel
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
2003 StandoutScience
Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9
2008 StandoutNobel
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
2001 StandoutNature
Innate immune sensing and its roots: the story of endotoxin
2003 StandoutNobel
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Friends or foes — bipolar effects of the tumour stroma in cancer
2004
The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; A review
2006
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Toll-like Receptors and Innate Immunity
2001
The biology and management of non-small cell lung cancer
2018 StandoutNature
Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments
2002
The p38 Mitogen-activated Kinase Pathway Regulates the Human Interleukin-10 Promoter via the Activation of Sp1 Transcription Factor in Lipopolysaccharide-stimulated Human Macrophages
2001
Sensitizing Anthrax Lethal Toxin-resistant Macrophages to Lethal Toxin-induced Killing by Tumor Necrosis Factor-α
2003 StandoutNobel
Lung Cancer
2008 Standout
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
2001 StandoutNature
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Sequential Activation of Signaling Pathways during Innate Immune Responses in Drosophila
2002
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
1997 Nature
Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation
1998
Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes
2016
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Regulation of Chemokine Expression by Antiinflammatory Cytokines
2002
Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements
1999
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
1999 Standout
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Toll-like receptors in the induction of the innate immune response
2000 StandoutNature
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
2000 Standout
Necrotizing Enterocolitis
2011 Standout
The immune response of Drosophila
2003 StandoutNatureNobel
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
Mammalian MAP kinase signalling cascades
2001 StandoutNature
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling
2003 StandoutNatureNobel
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
2011
Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways
1998
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
The TNF and TNF Receptor Superfamilies
2001 Standout
The inflammatory reflex
2002 StandoutNature
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Tumor Angiogenesis
2008 Standout
Pathogen Recognition and Innate Immunity
2006 Standout
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Preferential activation of the p46 isoform of JNK/SAPK in mouse macrophages by TNFα
1997
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice
2005 StandoutNobel
The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
2009 StandoutNature
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation
2002
Divergent Response to LPS and Bacteria in CD14-Deficient Murine Macrophages
2000
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis
2006 StandoutNobel
A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease
2003 StandoutNobel
The Host Defense of Drosophila melanogaster
2007 StandoutNobel
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection
2004 StandoutNobel
Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
2007
Toll‐like receptors: molecular mechanisms of the mammalian immune response
2000
Heme oxygenase/carbon monoxide signaling pathways: Regulation and functional significance
2002
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms
2004
Plant and Animal Sensors of Conserved Microbial Signatures
2010 StandoutScienceNobel
CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation
1998
Lipopolysaccharide Activates Distinct Signaling Pathways in Intestinal Epithelial Cell Lines Expressing Toll-Like Receptors
2000
Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis
2000
Works of J. Hambleton being referenced
Bevacizumab in combination with 5-FU/leucovorin improves survival in patients with metastatic colorectal cancer: A combined analysis
2004
Safety of bevacizumab (BV) among patients (pts) receiving first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): Preliminary results from a larger registry in the U.S
2005
Bevacizumab does not increase bleeding in patients with metastatic colorectal cancer receiving concurrent anticoagulation
2004
Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events.
1995
Bevacizumab in combination with 5-FU/leucovorin improves survival in patients with metastatic colorectal cancer: A combined analysis
2004
The role of tyrosine kinases and map kinases in LPS-induced signaling.
1998
Bevacizumab in patients with advanced platinum-resistant ovarian cancer
2006
Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab
2011
Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages.
1996